GCM
MRK icon

Gladius Capital Management’s Merck MRK Stock Holding History

Gladius Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.77M Buy
+81,200
New +$9.37M 0.44% 61
2025
Q2 		– Sell
-25,300
Closed -$2.27M – 74
2025
Q1 		$2.27M Sell
25,300
-16,700
-40% -$1.56M 0.6% 45
2024
Q4 		$4.18M Sell
42,000
-1,200
-3% -$124K 0.45% 38
2024
Q3 		$4.91M Buy
43,200
+26,800
+163% +$3.18M 0.59% 30
2024
Q2 		$2.03M Buy
16,400
+1,900
+13% +$245K 0.25% 49
2024
Q1 		$1.91M Sell
14,500
-19,100
-57% -$2.35M 0.63% 29
2023
Q4 		$3.66M Sell
33,600
-54,200
-62% -$5.63M 0.57% 36
2023
Q3 		$9.04M Buy
87,800
+37,100
+73% +$4M 0.38% 55
2023
Q2 		$5.85M Sell
50,700
-30,500
-38% -$3.46M 0.29% 40
2023
Q1 		$8.64M Buy
81,200
+65,200
+408% +$7.04M 0.5% 42
2022
Q4 		$1.78M Sell
16,000
-20,000
-56% -$2.04M 0.13% 47
2022
Q3 		$3.1M Buy
36,000
+18,900
+111% +$1.69M 0.14% 65
2022
Q2 		$1.56M Buy
17,100
+9,200
+116% +$816K 0.08% 79
2022
Q1 		$649K Buy
+7,900
New +$623K 0.05% 89
2021
Q2 		– Sell
-210,334
Closed -$15.5M – 159
2021
Q1 		$15.5M Buy
210,334
+36,052
+21% +$2.66M 0.58% 47
2020
Q4 		$13.6M Buy
174,282
+146,405
+525% +$11.2M 0.67% 51
2020
Q3 		$2.21M Buy
+27,877
New +$2.18M 0.22% 59
2020
Q2 		– Sell
-43,911
Closed -$3.22M – 90
2020
Q1 		$3.22M Sell
43,911
-67,282
-61% -$5.29M 0.34% 26
2019
Q4 		$9.65M Sell
111,193
-476,630
-81% -$39.1M 0.61% 35
2019
Q3 		$47.2M Buy
587,823
+173,863
+42% +$13.9M 2.15% 6
2019
Q2 		$33.5M Buy
413,960
+203,417
+97% +$15.6M 1.99% 9
2019
Q1 		$16.7M Buy
210,543
+2,620
+1% +$196K 0.92% 21
2018
Q4 		$15.2M Buy
207,923
+186,439
+868% +$13.2M 0.74% 29
2018
Q3 		$1.45M Sell
21,484
-5,240
-20% -$334K 0.14% 34
2018
Q2 		$1.55K Buy
+26,724
New +$1.51M 0.16% 41

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gladius Capital Management's MRK Position: Q1 2026 in Review

Gladius Capital Management opened a new position in Merck (MRK) in Q1 2026: 7,500 shares worth $902K. The stake represents 0.04% of the portfolio and ranks #93 among its holdings. This is a return to the name: Gladius Capital Management previously reported a position in MRK as recently as Q1 2025.

Gladius Capital Management first reported a position in MRK in Q2 2018 and has held it in 23 quarters since. The position peaked at $5.16M in Q3 2019. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Gladius Capital Management held 7,500 shares of Merck worth $902K as of Q1 2026.
  • Merck was a new Gladius Capital Management position in Q1 2026.
  • Merck made up 0.04% of Gladius Capital Management's portfolio in Q1 2026, its #93 holding.
  • Gladius Capital Management first reported a position in Merck in Q2 2018 and has held it in 23 quarters since.
  • Gladius Capital Management's Merck position peaked at $5.16M in Q3 2019.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Gladius Capital Management's 13F filing for Q1 2026, filed 7 May 2026.